1,2-dimethylhydrazine increases expression ISO RGD:1551030 6480464 1, 2-Dimethylhydrazine results in increased expression of ADGRG6 mRNA CTD PMID:22206623 1-nitropyrene increases expression ISO RGD:1318390 6480464 1-nitropyrene results in increased expression of ADGRG6 mRNA CTD PMID:19041380 17beta-estradiol multiple interactions ISO RGD:1318390 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ADGRG6 mRNA CTD PMID:19619570 17beta-estradiol decreases expression ISO RGD:1318390 6480464 Estradiol results in decreased expression of ADGRG6 mRNA CTD PMID:19619570 , PMID:21185374 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1318390 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ADGRG6 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ADGRG6 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ADGRG6 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1318390 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADGRG6 mRNA CTD PMID:19619570 , PMID:20106945 2,3,7,8-Tetrachlorodibenzofuran affects expression EXP 6480464 2 more ... CTD PMID:32109520 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1551030 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ADGRG6 mRNA CTD PMID:20188158 4,4'-sulfonyldiphenol increases expression ISO RGD:1551030 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ADGRG6 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1551030 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of ADGRG6 mRNA CTD PMID:30951980 5-fluorouracil affects response to substance ISO RGD:1318390 6480464 ADGRG6 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ADGRG6 mRNA CTD PMID:24780913 , PMID:25825206 aflatoxin B1 decreases methylation ISO RGD:1318390 6480464 Aflatoxin B1 results in decreased methylation of ADGRG6 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1318390 6480464 Tretinoin results in increased expression of ADGRG6 mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions ISO RGD:1551030 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of ADGRG6 mRNA, [bisphenol F co-treated with Tretinoin] results in decreased expression of ADGRG6 mRNA CTD PMID:30951980 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of ADGRG6 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO RGD:1318390 6480464 aristolochic acid I results in decreased expression of ADGRG6 mRNA CTD PMID:33212167 asbestos affects expression ISO RGD:1318390 6480464 Asbestos affects the expression of ADGRG6 mRNA CTD PMID:17297452 benzo[a]pyrene affects methylation ISO RGD:1551030 6480464 Benzo(a)pyrene affects the methylation of ADGRG6 intron CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1551030 6480464 Benzo(a)pyrene results in increased methylation of ADGRG6 exon CTD PMID:27901495 beta-naphthoflavone decreases expression ISO RGD:1318390 6480464 beta-Naphthoflavone results in decreased expression of ADGRG6 mRNA CTD PMID:32858204 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1318390 6480464 Diethylhexyl Phthalate results in increased expression of ADGRG6 mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:1551030 6480464 bisphenol A results in increased expression of ADGRG6 mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ADGRG6 mRNA CTD PMID:30816183 bisphenol F multiple interactions ISO RGD:1551030 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ADGRG6 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:1551030 6480464 bisphenol F results in increased expression of ADGRG6 mRNA CTD PMID:30951980 caffeine decreases phosphorylation ISO RGD:1318390 6480464 Caffeine results in decreased phosphorylation of ADGRG6 protein CTD PMID:35688186 carbamazepine affects expression ISO RGD:1318390 6480464 Carbamazepine affects the expression of ADGRG6 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1551030 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene decreases expression ISO RGD:1551030 6480464 Chloroprene results in decreased expression of ADGRG6 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1551030 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADGRG6 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADGRG6 gene CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ADGRG6 mRNA CTD PMID:22023808 clothianidin decreases expression ISO RGD:1318390 6480464 clothianidin results in decreased expression of ADGRG6 mRNA CTD PMID:31626844 cobalt dichloride decreases expression ISO RGD:1318390 6480464 cobaltous chloride results in decreased expression of ADGRG6 mRNA CTD PMID:19320972 copper(II) sulfate increases expression ISO RGD:1318390 6480464 Copper Sulfate results in increased expression of ADGRG6 mRNA CTD PMID:19549813 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ADGRG6 mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO RGD:1318390 6480464 Cyclosporine results in decreased expression of ADGRG6 mRNA CTD PMID:25562108 dioxygen multiple interactions ISO RGD:1551030 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADGRG6 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:1318390 6480464 Oxygen deficiency results in increased expression of ADGRG6 mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO RGD:1318390 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1318390 6480464 Doxorubicin results in increased expression of ADGRG6 mRNA CTD PMID:30031762 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of ADGRG6 mRNA CTD PMID:29391264 entinostat multiple interactions ISO RGD:1318390 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRG6 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1318390 6480464 entinostat results in increased expression of ADGRG6 mRNA CTD PMID:26272509 fenamidone increases expression ISO RGD:1551030 6480464 fenamidone results in increased expression of ADGRG6 mRNA CTD PMID:27029645 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of ADGRG6 mRNA CTD PMID:30307764 folic acid multiple interactions ISO RGD:1551030 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADGRG6 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADGRG6 gene CTD PMID:20938992 genistein increases expression ISO RGD:1551030 6480464 Genistein results in increased expression of ADGRG6 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ADGRG6 mRNA CTD PMID:22061828 , PMID:33387578 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ADGRG6 mRNA CTD PMID:22129741 L-methionine multiple interactions ISO RGD:1551030 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADGRG6 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADGRG6 gene CTD PMID:20938992 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of ADGRG6 mRNA CTD PMID:22641619 mercury dibromide increases expression ISO RGD:1318390 6480464 mercuric bromide results in increased expression of ADGRG6 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1318390 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRG6 mRNA CTD PMID:27188386 methylmercury chloride decreases expression ISO RGD:1318390 6480464 methylmercuric chloride results in decreased expression of ADGRG6 mRNA CTD PMID:23179753 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ADGRG6 mRNA CTD PMID:22129741 panobinostat multiple interactions ISO RGD:1318390 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRG6 mRNA CTD PMID:27188386 paracetamol decreases expression ISO RGD:1318390 6480464 Acetaminophen results in decreased expression of ADGRG6 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of ADGRG6 mRNA CTD PMID:33387578 phenylmercury acetate increases expression ISO RGD:1318390 6480464 Phenylmercuric Acetate results in increased expression of ADGRG6 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1318390 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRG6 mRNA CTD PMID:27188386 potassium chromate decreases expression ISO RGD:1318390 6480464 potassium chromate(VI) results in decreased expression of ADGRG6 mRNA CTD PMID:22714537 progesterone increases expression ISO RGD:1318390 6480464 Progesterone results in increased expression of ADGRG6 mRNA CTD PMID:18070364 quercitrin decreases expression ISO RGD:1318390 6480464 quercitrin results in decreased expression of ADGRG6 mRNA CTD PMID:25193878 rofecoxib affects expression ISO RGD:1318390 6480464 rofecoxib affects the expression of ADGRG6 mRNA CTD PMID:17070997 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ADGRG6 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1318390 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sunitinib decreases expression ISO RGD:1318390 6480464 Sunitinib results in decreased expression of ADGRG6 mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression ISO RGD:1318390 6480464 tert-Butylhydroperoxide results in decreased expression of ADGRG6 mRNA CTD PMID:15336504 tetrachloromethane affects expression ISO RGD:1551030 6480464 Carbon Tetrachloride affects the expression of ADGRG6 mRNA CTD PMID:17484886 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ADGRG6 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1551030 6480464 titanium dioxide results in decreased expression of ADGRG6 mRNA CTD PMID:23557971 triadimefon decreases expression ISO RGD:1318390 6480464 triadimefon results in decreased expression of ADGRG6 mRNA CTD PMID:26705709 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ADGRG6 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1318390 6480464 trichostatin A results in increased expression of ADGRG6 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1318390 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRG6 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1318390 6480464 Triclosan results in decreased expression of ADGRG6 mRNA CTD PMID:30510588 triptonide decreases expression ISO RGD:1551030 6480464 triptonide results in decreased expression of ADGRG6 mRNA CTD PMID:33045310 valproic acid increases expression ISO RGD:1551030 6480464 Valproic Acid results in increased expression of ADGRG6 mRNA CTD PMID:24896083 valproic acid increases expression ISO RGD:1318390 6480464 Valproic Acid results in increased expression of ADGRG6 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1318390 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRG6 mRNA CTD PMID:27188386
